The liberalization of the bench medicines

The thesis proposes a detailed analysis of the druggist field and, in particular, of the organization, the operation and the tasks of the market of the drug.
In the first one understood the iter is travelled over again it legislative of the sanitary ordering, in order better to comprise through which transformations and structural reforms it has been reached it puts into effect them healthy system and to one new idea of Health. The second understood analyzes it the scientific information on the drug that represents the complex of data clinical-pharmacological who the druggist companies supply to operating the sanitary ones so as to correctly address them in the choice and the use of the medicinal one. The third party understood is dedicated it to the law by decree number 87 of 27 May 2005. It has been attempted to put in relief the single aspects in it previewed, being offered in particular one description detailed of the stages of the introduction of drugs in the such GDO after decree. It has been proposed, moreover, a hypothesis on the reasons subtended to the choice of the model of the agency and, therefore, an administration separated from that one be them and the relative consequences. In the quarter understood it the situation of various European countries is analyzed, considering at last the Italian situation. The scope of the present job is just that one to delineate the factors that favor the innovation in the druggist field and the increase of the competition. One agrees to carry out a surveying empiricist turns to analyze the role of the State and the companies like competitive instrument.

Mostra/Nascondi contenuto.
INTRODUCTION The thesis proposes a detailed analysis of the druggist field and, in particular, of the organization, the operation and the tasks of the market of the drug. In the first one understood the iter is travelled over again it legislative of the sanitary ordering, in order better to comprise through which transformations and structural reforms it has been reached it puts into effect them healthy system and to one new idea of Health. The second understood analyzes it the scientific information on the drug that represents the complex of data clinical-pharmacological who the druggist companies supply to operating the sanitary ones so as to correctly address them in the choice and the use of the medicinal one. The third party understood is dedicated it to the law by decree number 87 of 27 May 2005. It has been attempted to put in relief the single aspects in it previewed, being offered in particular one description detailed of the stages of the introduction of drugs in the such GDO after decree. It has been proposed, moreover, a hypothesis on the reasons subtended to the choice of the model of the agency and, therefore, an administration separated from that one be them and the relative consequences. In the quarter understood it the situation of various European countries is analyzed, considering at last the Italian situation. The scope of the present job is just that one to delineate the factors that favor the innovation in the druggist field and the increase of the competition. One agrees to carry out a surveying empiricist turns to analyze the role of the State and the companies like competitive instrument. 1

Laurea liv.I

Facoltà: Economia

Autore: Maria Irman Tripaldi Contatta »

Composta da 35 pagine.

 

Questa tesi ha raggiunto 23 click dal 07/03/2014.

Disponibile in PDF, la consultazione è esclusivamente in formato digitale.